Skip to main content
PeptidePicker
Home/Peptides/Triptorelin
ClinicalFDA Approved

Triptorelin

Also known as: Trelstar · Decapeptyl

A potent GnRH agonist used for prostate cancer suppression and as a single-shot HPTA restart protocol after prolonged steroid use.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~3–5 hours

Typical Dose

100 mcg (single PCT dose) or depot injection (clinical)

Administration

Intramuscular injection

Mechanism of Action

Continuous GnRH receptor stimulation causes initial LH/FSH spike followed by receptor downregulation and complete gonadal suppression.

Key Research Areas

GnRHprostate cancerPCThormone suppression

Frequently Asked Questions

What is Triptorelin?▾
A potent GnRH agonist used for prostate cancer suppression and as a single-shot HPTA restart protocol after prolonged steroid use.
How does Triptorelin work?▾
Continuous GnRH receptor stimulation causes initial LH/FSH spike followed by receptor downregulation and complete gonadal suppression.
What is the recommended dosage for Triptorelin?▾
The typical research dosage is 100 mcg (single PCT dose) or depot injection (clinical), administered via Intramuscular injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Triptorelin?▾
The half-life of Triptorelin is approximately ~3–5 hours. This affects dosing frequency and timing in research protocols.
Is Triptorelin FDA approved?▾
Yes, Triptorelin is FDA approved for specific medical indications. Consult your physician for proper medical guidance.

Ready to get started with Triptorelin?

Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.

99%+ purity verifiedCOA with every orderFree priority shipping
Order Triptorelin

Research Disclaimer

The information provided about Triptorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Clinical